In lung cancer cells, ABC transporter inhibitors elevated intracellular ROS levels and augmented the cytotoxicity of chemicals, thereby underscoring the essential detoxification role these transporters play [41]. This evidence concerns the gene ABCG2 and lung carcinoma.